Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic reviewScott A. Laurie, David G. Pfister, Alan L. Ho et al.|The Lancet Oncology|2010Cited by 394
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced MelanomaOmid Hamid, Giuseppe Gullo, Karl D. Lewis et al.|Journal of Clinical Oncology|2024Cited by 37